Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Brief Cognitive Behaviour Therapy to Prevent Suicide Reattempts in Swedish Psychiatric Inpatient Care

Official title: Brief Cognitive Behaviour Therapy to Prevent Suicide Reattempts: A Feasibility Study in Swedish Psychiatric Inpatient Care

Run by Karolinska Institutet · NCT07567885 · Data updated 2026-11-12

This study tests whether four brief CBT sessions can be delivered during a psychiatric hospital stay to help adults who recently attempted suicide or are at high risk see if the treatment works and is easy to use in routine care.

More Suicide Attempt trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment32 (estimated)
SponsorKarolinska Institutet
Academic / other
Locations1 site (Stockholm)
StatusRecruiting
StartedMay 11, 2026
Main results expectedDecember 14, 2026
Study endsDecember 14, 2027
Registry record updatedAugust 17, 2026
Trial IDNCT07567885 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) admitted to Swedish inpatient psychiatric care after a suicide attempt or with active suicidal ideation and recent planning, able to consent and expected to stay for at least four working days.

Probably not a fit

Individuals with ongoing mania, acute psychosis, certain cognitive impairments, or conditions preventing informed consent may not benefit from this approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a single-arm feasibility study to determine if Brief Cognitive Behaviour Therapy (BCBT) can be feasibly implemented for adults in inpatient psychiatric care in Sweden. Participants will receive four structured BCBT sessions in addition to usual care during hospitalization, with follow-up assessments at 1 and 3 months after treatment. The study focuses on acceptability to patients and feasibility from the perspectives of clinicians and hospital administration, aiming to identify barriers and facilitators to routine implementation. BCBT is based on cognitive-behavioral principles and the Fluid Vulnerability Theory of suicide, targeting modifiable cognitive, emotional, and behavioral factors to reduce ongoing suicide risk. The trial will enroll about 20 participants aged 18 or older, admitted after a suicide attempt or with active suicidal ideation and recent plan, across Karolinska Institutet and Region Stockholm sites.

Why it matters

Potential benefit: If successful, patients may experience reduced risk of future suicide attempts and improved coping during the high-risk post-discharge period.

How similar studies have gone: Evidence from similar brief CBT approaches for suicidality has shown promise in other settings, but this is a novel feasibility assessment within Swedish inpatient care.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* admitted following a suicide attempt within one week of admission or presenting with suicidal ideation with a plan and a prior suicide attempt within the last two years
* 18 years or older

Exclusion Criteria:

* current mania, current acute psychosis, or cognitive impairment
* expected inpatient stay shorter than four working days
* ongoing or planned electroconvulsive therapy
* psychiatric or somatic conditions leading to inability to provide informed consent

Where it's running

  • Psykiatri Sydväst
    Stockholm, Sweden
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.